Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea: A 52-week randomized trial

Bibliographic Details
Main Authors: Schernthaner, Guntram, Gross, Jorge L., Rosenstock, Julio, Guarisco, Michael, Fu, Min, Yee, Jacqueline, Kawaguchi, Masato, Canovatchel, William, Meininger, Gary
Format: Online
Language:English
Published: American Diabetes Association 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747923/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747923/

Similar Items